Funded Tech Companies

Inflammatix

Wondering who provided funding to Inflammatix? Raw Ventures, Think.Health and Iberis Capital invested in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Inflammatix is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. We are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/12/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Timothy Sweeney

        

Chief Medical Officer

Oliver Liesenfeld

        

Chief Technical Officer

Joao Fonseca

        

Co-Founder

Purvesh Khatri

        

Vice President

Ljubomir Buturovic

        

Vice President

Yudong He

        

Vice President

Pamela Lambert

        

VP - Bus. Development

Jonathan Romanowsky

        

VP - Engineering

Paul Fleming

        

VP - Finance

Howard Solovei

        

VP - Marketing

Nina Menezes

        

VP - Regulatory Affairs

Diana Lane

        

Company Investors

• Raw Ventures
• Think.Health
• Iberis Capital
• OSF Healthcare
• D1 Capital Partners (James Rogers)
• Khosla Ventures
• Northpond Ventures (Michael Rubin)
• Vesalius Biocapital
• OSF Ventures
• Grey Sky Venture Partners

Browse more funded tech companies:

Infisical | Inflazome

Share this article

About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary